| Symbol | Name | Grade | Market Cap | Country |
|---|---|---|---|---|
| 603259.CN | WuXi AppTec Co., Ltd. Class A | 87.3 | ¤65,547 | CN |
| 002001.CN | Zhejiang NHU Co. Ltd. Class A | 75.3 | ¤11,780 | CN |
| 002653.CN | Haisco Pharmaceutical Group Co. Ltd. Cla | 69.6 | ¤10,303 | CN |
| 688578.CN | Shanghai Allist Pharmaceuticals Co. Ltd. | 90.8 | ¤5,697 | CN |
| 688336.CN | Sunshine Guojian Pharmaceutical (Shangha | 92.1 | ¤4,615 | CN |
| Symbol | Name | Grade | Market Cap | Country |
|---|---|---|---|---|
| 300515.CN | Hunan Sundy Science and Technology Co., | 78.7 | ¤468 | CN |
| 002107.CN | Shandong Wohua Pharmaceutical Co., Ltd. | 59.2 | ¤552 | CN |
| 688580.CN | Nanjing Vishee Medical Technology Co., L | 57.7 | ¤577 | CN |
| 300871.CN | Hvsen Biotechnology Co. Ltd. Class A | 60.0 | ¤587 | CN |
| 688410.CN | SWS Hemodialysis Care Co., Ltd. Class A | 62.1 | ¤637 | CN |
| Symbol | Name | Grade | Times* | Country |
|---|---|---|---|---|
| 002001.CN | Zhejiang NHU Co. Ltd. Class A | 75.3 | 21 | CN |
| 000423.CN | Dong-E-E-Jiao Co., Ltd. Class A | 64.1 | 20 | CN |
| 600285.CN | Henan Lingrui Pharmaceutial Co., Ltd. Cl | 60.3 | 10 | CN |
| 600867.CN | Tonghua Dongbao Pharmaceutical Co., Ltd. | 69.2 | 10 | CN |
| 002107.CN | Shandong Wohua Pharmaceutical Co., Ltd. | 59.2 | 8 | CN |
| 300453.CN | Jiang Xi Sanxin Medtec Co Ltd Class A | 66.2 | 8 | CN |
| 002603.CN | Shijiazhuang Yiling Pharmaceutical Co., | 56.3 | 6 | CN |
| 688578.CN | Shanghai Allist Pharmaceuticals Co. Ltd. | 90.8 | 6 | CN |
| 002437.CN | Harbin Gloria Pharmaceuticals Co., Ltd. | 60.5 | 5 | CN |
| 300206.CN | Edan Instruments, Inc. Class A | 66.4 | 5 | CN |
| Average Market Cap | ¤4,618 |
| Median Market Cap | ¤1,442 |
| Avg. 3 Mo. Dollar Vol. | ¤77,398,157 |
| Avg. 3 Mo. Trading Vol. | 21,665,978 |
| Last Rebalance Date | 06/15/2026 |
| Companies Replaced | 16 |
| Biggest Sector Increase | Health Care |
| Biggest Sector Decrease | Health Care |
| Trailing P/E Ratio (12 Mo.) | 21.5 |
| Forward P/E Ratio (12 Mo.) | 23.5 |
| Price/Book Ratio | 3.3 |
| Avg. Revenue Chg. - 3 Yr | 46.6% |
| Avg. Op. Income Chg. - 3 Yr. | 52.5% |
| Avg. EPS Growth - 3 Yr. | 19.2% |
| Avg. EPS Growth - 1 Yr. | 10.3% |
| Avg. Operating Margin | 20.5% |
| Avg. LT Debt to Total Capital | 7.1% |
| Avg. Return on Equity | 17.4% |
| Dividend Yield | 1.8% |
| China Health Care Index | 62.56 |
| China | 100.0% |
